ART and HPTN 052: Where did we come from and where are we going

Webcast date

February 16, 2012

Myron Cohen, MD

University of North Carolina, Chapel Hill

Myron S. Cohen is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina at Chapel Hill. Dr. Cohen received his BS degree (Magna Cum Laude) from the University of Illinois, Champaign-Urbana. He received an MD degree from Rush Medical College, Chicago Illinois. He completed an Infectious Disease Fellowship at Yale University

Dr. Cohen serves as the Director of the UNC Division of Infectious Disease and the UNC Institute for Global Health and Infectious Disease, and Associate Vice Chancellor for Global Health. Dr. Cohen received the Distinguished Alumnus Award from Rush Medical College in 2000. He received the Thomas Parran Award (2005) for lifetime achievement in STD research from the American Sexually Transmitted Diseases Association. In 2008 Dr. Cohen received the O. Max Gardner Award, the highest honor in the University of North Carolina 16 campus system

Dr. Cohen’s research work focuses on the transmission and prevention of transmission of HIV. Dr. Cohen is the architect and Principal Investigator of the multinational study HPTN 052, which proved that antiretroviral treatment prevents the sexual transmission of HIV-1. This was recognized in 2011 by Science Magazine as the “Breakthrough of the Year”. Dr. Cohen is the author of more than 500 publications. Much of Dr. Cohen’s research has been conducted in resource constrained countries, especially in the African country of Malawi and in the People’s Republic of China.

View webcast